Search clinical trials for: Etarfolatide (EC20)

Total 46 results

Endocyte

Completed

Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers

Healthy

United States
Endocyte

Completed

An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery

Ovary Cancer

Canada, United States
Endocyte

Completed

Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)

Adenocarcinoma of the Lung
Endocyte

Completed

Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors

Solid Tumors | Non Small Cell Lung Carcinoma

United States
Endocyte

Completed

Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer (TARGET)

Non Small Cell Lung Cancer
Virginia Kraus
Eli Lilly and Company; Endocyte

Completed

A Study of FolateScan in Patients With Knee Osteoarthritis

Knee Osteoarthritis

United States
Invendo Medical GmbH

Terminated

Single Arm Post-marketing Study of SC20 Colonoscope (SC20 Scope)

Gentle Colonoscopy

United States
Fujifilm Medical Systems USA, Inc.

Completed

AI Colorectal Polyp Detection

Adenoma Colon | Polyp Colorectal

United States
Endocyte

Completed

Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) (PRECEDENT)

Ovarian Cancer
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors

Pituitary Tumors

United States
Endocyte

Completed

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Head and Neck Cancer | Bladder Cancer | Pancreas Cancer | Testicular Cancer | Recurrent or Metastatic Cancer
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer

Ovarian Cancer | Endometrial Cancer

United States
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Endocyte

Completed

Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma

Recurrent Endometrial Carcinoma | Ovarian Carcinoma
Endocyte

Completed

Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients

Ovarian Cancer | Healthy Volunteers

United States
Endocyte

Completed

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Bayer

Completed

YAZ Post-marketing Surveillance in Japan

Dysmenorrhea

Japan
Kolding Sygehus

Completed

Telemedicine Strategy With Home Treatment Save Resources

Type 2 Diabetes Mellitus

Denmark
Medtronic BRC
Medtronic

Completed

Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study (RARE-PEARL)

Permanent Atrial Fibrillation

Italy
Bayer

Completed

Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

Contraception

Netherlands, Canada, Germany
Bayer

Completed

Regulatory Post Marketing Surveillance Study on YAZ

Contraception | Acne | Premenstrual Syndrome

Korea, Republic of
Bayer

Withdrawn

To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea

Dysmenorrhea
LUTRONIC Corporation

Unknown

Histologic Evaluation of Tissue Following Lutronic System Exposure

Abdominoplasty

United States
Bayer

Completed

Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea

Dysmenorrhea

Japan
Bayer

Completed

YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

Contraception

China
Swedish Red Cross University College
Karolinska University Hospital; Karolinska Institutet; Norwegian University of... and other collaborators

Completed

Central Catheters Used for Chemotherapy in Women With Breast Cancer (PICC&PAC)

Catheter Related Complications

Sweden
Bayer

Completed

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

Contraception | Ovulation Inhibition | Contraceptives, Oral

United States
Bayer

Completed

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

Premenstrual Dysphoric Disorder ( PMDD)

China
Bayer

Withdrawn

Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

Contraception
Bayer

Completed

Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception

Contraception

Mexico
Alkeus Pharmaceuticals, Inc.

Completed

Phase 1 Safety Study of ALK-001 in Healthy Volunteers

Age-related Macular Degeneration | Stargardt Disease | Other Retinal Dystrophies
Alkeus Pharmaceuticals, Inc.

Enrolling by invitation

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Stargardt Disease | Stargardt Macular Degeneration | Stargardt Macular Dystrophy | Autosomal Recessive Stargardt Disease 1 (ABCA4-related)

United States
Alkeus Pharmaceuticals, Inc.

Recruiting

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Stargardt Disease | Stargardt Macular Degeneration | Stargardt Macular Dystrophy | Autosomal Recessive Stargardt Disease 1 (ABCA4-related)

United States
Endocyte

Terminated

Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) (PROCEED)

Ovarian Cancer
Endocyte

Completed

Study of EC0225 for the Treatment of Refractory or Metastatic Tumors

Cancer

United States
Alkeus Pharmaceuticals, Inc.

Active, not recruiting

Phase 3 Study of ALK-001 in Geographic Atrophy (SAGA)

Geographic Atrophy | Age Related Macular Degeneration | AMD | Atrophy, Geographic

United States
Endocyte

Completed

Study of EC0489 for the Treatment of Refractory or Metastatic Tumors

Cancer

United States
Endocyte

Withdrawn

Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)

Breast Neoplasms
Bayer

Completed

GA YAZ ACNE in China Phase III

Acne Vulgaris

China
University of Sydney
Telethon Kids Institute; Bionet Co., Ltd; Technovalia; Institute for Clinical Pathology...

Completed

The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers (COVALIA)

SARS-CoV2 COVID-19

Australia
Bayer

Completed

Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis

Endometriosis

Japan
Bayer

Completed

Comparative Trial in Hormone Withdrawal Associated Symptoms

Oral Contraceptive

Switzerland, Portugal, Chile, Italy, Korea, Republic of, Venezuela, Philippines, Colombia, Thailand, Argentina, Germany, Russian Federation, United Kingdom, Czech Republic
Endocyte

Terminated

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Bayer

Completed

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)

Contraception

Netherlands
Endocyte

Completed

Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer

Cancer

United States
Breath of Life International Pharma Ltd

Completed

A Phase I Open Label Study to Assess PK and Safety of Plant Cannabis Extract

Healthy

Israel

3

Subscribe